A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause
Clinical trial NCT05033886 · COMPLETED
Trial details
- NCT number
- NCT05033886
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-08
- Primary completion
- 2023-03-27
- Enrollment
- 453
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.